Alps Group Posts 44% Revenue Growth in FY2026 as Nasdaq-Listed Biotech Sharpens Precision Medicine Focus
at www.tipranks.com (Fri, 7-Aug 4:47 PM)
Alps Group Inc GAAP EPS of -$0.02, revenue of $4.9M
at seekingalpha.com (Fri, 7-Aug 8:07 AM)
